MeSH term
Frequency | Condition_Probility | Animals | 54 | 0.0 |
Casein Kinase II | 4 | 3.0 |
Cell Line | 24 | 0.0 |
Enzyme Inhibitors/metabolism | 2 | 0.0 |
Humans | 84 | 0.0 |
Mice | 37 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Phosphorylation | 6 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Protein Binding | 13 | 0.0 |
Repressor Proteins/genetics/*metabolism | 3 | 1.0 |
Research Support, Non-U.S. Gov't | 78 | 0.0 |
Transcription Factors/genetics/*metabolism | 8 | 1.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
Ubiquitin/*metabolism | 2 | 1.0 |
DNA-Binding Proteins/*metabolism | 6 | 0.0 |
Gene Expression Regulation, Neoplastic/*physiology | 3 | 1.0 |
Helix-Loop-Helix Motifs/physiology | 2 | 22.0 |
Immunohistochemistry | 18 | 0.0 |
*Repressor Proteins | 52 | 4.0 |
Transcription Factors/*metabolism | 9 | 0.0 |
Female | 23 | 0.0 |
Blotting, Western | 8 | 0.0 |
*Cell Differentiation | 2 | 0.0 |
Dimerization | 2 | 0.0 |
MyoD Protein/*metabolism | 2 | 15.0 |
*Neoplasm Proteins | 15 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 37 | 0.0 |
Transcription, Genetic | 8 | 0.0 |
Transfection | 14 | 0.0 |
COS Cells | 3 | 0.0 |
Cattle | 3 | 0.0 |
Cell Division | 11 | 0.0 |
Cells, Cultured | 16 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Helix-Loop-Helix Motifs | 22 | 9.0 |
Kinetics | 3 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Trans-Activators/metabolism | 5 | 0.0 |
Transcription Factors/genetics | 8 | 0.0 |
Adolescent | 4 | 0.0 |
Adult | 9 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Child | 3 | 0.0 |
Follow-Up Studies | 3 | 0.0 |
Male | 20 | 0.0 |
Middle Aged | 10 | 0.0 |
Pregnancy | 3 | 0.0 |
Cell Differentiation | 13 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 7 | 0.0 |
Neurons/*physiology | 2 | 1.0 |
Promoter Regions (Genetics) | 10 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Astrocytes/*cytology | 2 | 25.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
*Proteins | 2 | 0.0 |
*Receptors, Growth Factor | 2 | 6.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
*Transforming Growth Factor beta | 7 | 4.0 |
Antibodies, Monoclonal/diagnostic use | 2 | 0.0 |
Astrocytes/metabolism | 3 | 4.0 |
Cell Division/physiology | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Helix-Loop-Helix Motifs/genetics | 2 | 5.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
Oligodendroglia/metabolism | 2 | 4.0 |
Phenotype | 4 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Rats | 8 | 0.0 |
Transcription Factors/*genetics | 9 | 0.0 |
Base Sequence | 16 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Genes, Reporter | 5 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Time Factors | 4 | 0.0 |
beta-Galactosidase/metabolism | 2 | 1.0 |
Binding Sites | 6 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Signal Transduction | 5 | 0.0 |
Apoptosis | 2 | 0.0 |
*Gene Expression Profiling | 4 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Repressor Proteins/biosynthesis/genetics | 2 | 18.0 |
DNA-Binding Proteins/*physiology | 3 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Transcription Factors/physiology | 2 | 0.0 |
Up-Regulation | 7 | 0.0 |
Bone Morphogenetic Proteins/*pharmacology | 3 | 5.0 |
DNA-Binding Proteins/metabolism | 7 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Transcription Factors/metabolism/*physiology | 2 | 2.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
Cell Aging/*genetics | 2 | 6.0 |
Gene Expression Regulation | 7 | 0.0 |
Signal Transduction/genetics | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 2 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Cell Line, Tumor | 7 | 0.0 |
In Vitro | 2 | 0.0 |
Models, Biological | 4 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Repressor Proteins/*metabolism | 2 | 1.0 |
Comparative Study | 6 | 0.0 |
RNA, Messenger/analysis/biosynthesis | 2 | 0.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Bone Morphogenetic Proteins/*metabolism | 3 | 7.0 |
Cell Lineage | 2 | 0.0 |
Transcription Factors/metabolism | 5 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Risk Factors | 2 | 0.0 |
Cell Differentiation/*genetics | 2 | 2.0 |
Cell Lineage/genetics | 2 | 9.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
*Helix-Loop-Helix Motifs | 13 | 14.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
Transcription Factors/*biosynthesis | 3 | 2.0 |
*Gene Expression Regulation | 4 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
RNA, Small Interfering/genetics | 3 | 2.0 |
*Apoptosis | 2 | 0.0 |
Heat-Shock Proteins 90/genetics | 2 | 33.0 |
Histone Deacetylases/*antagonists & inhibitors | 2 | 4.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Neurons/metabolism | 2 | 0.0 |
RNA Interference | 3 | 1.0 |
Incidence | 2 | 0.0 |
DNA/biosynthesis | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
*Transcription Factors | 4 | 0.0 |
Prospective Studies | 2 | 0.0 |
Immunoenzyme Techniques | 4 | 0.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Helix-Loop-Helix Motifs/*genetics | 3 | 7.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Hydroxamic Acids/*pharmacology | 2 | 4.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Gene Expression | 6 | 0.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
DNA Primers/genetics | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Reference Values | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 3 | 0.0 |
*Proto-Oncogene Proteins | 5 | 0.0 |
DNA/metabolism | 4 | 0.0 |
Hela Cells | 5 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Mutation | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
3T3 Cells | 3 | 0.0 |
Cyclins/*genetics | 2 | 1.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
MyoD Protein/metabolism | 2 | 10.0 |
Amino Acid Sequence | 10 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Chromosome Mapping | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Consensus Sequence | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
*Transcription, Genetic | 5 | 0.0 |
Cell Cycle | 4 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Transcription Factor AP-1/metabolism | 2 | 0.0 |
DNA | 2 | 0.0 |
Genes, myc | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
*Chromosome Aberrations | 2 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Melanoma/*metabolism | 2 | 3.0 |
Protein Biosynthesis | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Cell Transformation, Neoplastic | 3 | 0.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
*Muscle Proteins | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
